doi: 10.1128/AAC.32.5.752.
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
Affiliations
- PMID: 2840016
- PMCID: PMC172265
- DOI: 10.1128/AAC.32.5.752
Item in Clipboard
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
Antimicrob Agents Chemother.
1988 May.
Abstract
The in vitro activity of azithromycin (CP 62,993 or XZ-450) against Haemophilus influenzae was greater than that of three other macrolides. However, azithromycin was four- to eightfold less active than erythromycin against the gram-positive cocci and against Listeria monocytogenes. Erythromycin and azithromycin were similar in their activity against Legionella pneumophila, Neisseria gonorrhoeae, Neisseria meningitidis, and Branhamella catarrhalis.
Similar articles
-
Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.Antimicrob Agents Chemother. 1988 Nov;32(11):1710-9. doi: 10.1128/AAC.32.11.1710. Antimicrob Agents Chemother. 1988. PMID: 3252753 Free PMC article.
-
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.Antimicrob Agents Chemother. 1987 Feb;31(2):343-5. doi: 10.1128/AAC.31.2.343. Antimicrob Agents Chemother. 1987. PMID: 2952064 Free PMC article.
-
Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.J Antimicrob Chemother. 1987 Nov;20 Suppl B:39-46. doi: 10.1093/jac/20.suppl_b.39. J Antimicrob Chemother. 1987. PMID: 3501426
-
[Azithromycin: critical points].Pathol Biol (Paris). 1995 Jun;43(6):488-97. Pathol Biol (Paris). 1995. PMID: 8539070 Review. French.
-
Clarithromycin and azithromycin: new macrolide antibiotics.Clin Pharm. 1992 Feb;11(2):137-52. Clin Pharm. 1992. PMID: 1312921 Review.
Cited by
-
Effects of environmental factors on the in vitro potency of azithromycin.Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):834-42. doi: 10.1007/BF01975836. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1662627
-
Influence of the test medium on azithromycin and erythromycin regression statistics.Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):846-9. doi: 10.1007/BF01975838. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1662629
-
Azithromycin through the Lens of the COVID-19 Treatment.Antibiotics (Basel). 2022 Aug 5;11(8):1063. doi: 10.3390/antibiotics11081063. Antibiotics (Basel). 2022. PMID: 36009932 Free PMC article. Review.
-
Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study.Infection. 1999 May-Jun;27(3):198-202. doi: 10.1007/BF02561528. Infection. 1999. PMID: 10378132 Clinical Trial.
-
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.Antimicrob Agents Chemother. 1992 Jan;36(1):10-6. doi: 10.1128/AAC.36.1.10. Antimicrob Agents Chemother. 1992. PMID: 1317141 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
